HB
CVS icon

Homrich & Berg’s CVS Health CVS Stock Holding History

Homrich & Berg’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$773K Sell
9,111
-3,032
-25% -$254K 0.02% 246
2021
Q2 		$1.01M Buy
12,143
+3,948
+48% +$323K 0.02% 211
2021
Q1 		$616K Sell
8,195
-77
-0.9% -$5.61K 0.02% 254
2020
Q4 		$565K Sell
8,272
-2,479
-23% -$161K 0.02% 258
2020
Q3 		$628K Sell
10,751
-1,186
-10% -$73.8K 0.02% 205
2020
Q2 		$776K Buy
11,937
+1,795
+18% +$113K 0.03% 174
2020
Q1 		$602K Sell
10,142
-22,887
-69% -$1.53M 0.03% 176
2019
Q4 		$2.45M Buy
33,029
+3,388
+11% +$238K 0.11% 72
2019
Q3 		$1.87M Sell
29,641
-1,597
-5% -$94.6K 0.1% 84
2019
Q2 		$1.7M Buy
31,238
+862
+3% +$46.4K 0.09% 90
2019
Q1 		$1.64M Buy
30,376
+13,065
+75% +$806K 0.09% 83
2018
Q4 		$1.13M Buy
17,311
+1,892
+12% +$141K 0.07% 112
2018
Q3 		$1.21M Buy
15,419
+33
+0.2% +$2.36K 0.07% 108
2018
Q2 		$990K Buy
15,386
+1,868
+14% +$123K 0.07% 117
2018
Q1 		$841K Buy
13,518
+2,925
+28% +$210K 0.06% 146
2017
Q4 		$768K Sell
10,593
-5,077
-32% -$369K 0.05% 156
2017
Q3 		$1.27M Buy
15,670
+5,637
+56% +$446K 0.1% 100
2017
Q2 		$807K Buy
10,033
+6,726
+203% +$531K 0.07% 117
2017
Q1 		$260K Sell
3,307
-163
-5% -$13K 0.02% 253
2016
Q4 		$274K Buy
3,470
+345
+11% +$27.9K 0.02% 229
2016
Q3 		$278K Buy
3,125
+187
+6% +$17.7K 0.03% 219
2016
Q2 		$281K Buy
2,938
+3
+0.1% +$299 0.03% 209
2016
Q1 		$304K Buy
2,935
+80
+3% +$7.78K 0.03% 197
2015
Q4 		$279K Buy
2,855
+380
+15% +$37.2K 0.03% 207
2015
Q3 		$239K Buy
2,475
+420
+20% +$44.2K 0.03% 223
2015
Q2 		$216K Sell
2,055
-49
-2% -$5.01K 0.02% 246
2015
Q1 		$217K Buy
+2,104
New +$213K 0.02% 233

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Homrich & Berg's CVS Position: Q3 2021 in Review

Homrich & Berg reduced its CVS Health (CVS) stake by 25% in Q3 2021, selling an estimated $254K and leaving 9,111 shares worth $773K. The position accounts for 0.02% of the portfolio, ranked #246.

Homrich & Berg first reported a position in CVS in Q1 2015 and has held it in 27 quarters since. The position peaked at $2.45M in Q4 2019. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Homrich & Berg held 9,111 shares of CVS Health worth $773K as of Q3 2021.
  • Homrich & Berg sold 3,032 CVS Health shares in Q3 2021, an estimated $254K.
  • CVS Health made up 0.02% of Homrich & Berg's portfolio in Q3 2021, its #246 holding.
  • Homrich & Berg first reported a position in CVS Health in Q1 2015 and has held it in 27 quarters since.
  • Homrich & Berg's CVS Health position peaked at $2.45M in Q4 2019.
  • 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.